16
Participants
Start Date
March 22, 2022
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
"Patients will receive six DC vaccinations Q3W (±3 days) in combination with low dose cyclophosphamide the day before vaccination.~Each dose of vaccine (PEP-DC) will be split into two injections, which will be administered on W2D2 of each cycle, subcutaneously. Patients will be vaccinated until vaccine exhaustion, disease progression, major toxicity or patient withdrawal, whichever is earlier. Additional DC vaccines may be administered Q3W (±3 days) if available until vaccine exhaustion or disease progression, whichever is earlier."
Low dose cyclophosphamide
Patients will receive six DC vaccinations Q3W (±3 days) in combination with low dose cyclophosphamide the day before vaccination.
CHUV Oncology Department, Lausanne
Centre Hospitalier Universitaire Vaudois
OTHER